Trial Condition(s):

Bacterial Infection

Ciprofloxacin in the treatment of pediatric patients with cystic fibrosis episodes caused by sensitive gram negative and gram positive bacteria

Bayer Identifier:

Trial_1131

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
24
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Cipro (Ciprofloxacin hydrochloride, BAYO9867)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information